Effects of modified huangfeng decoction on long-Term prognosis of patients with systemic lupus erythematosus complicated with antiphospholipid antibody syndrome in childbearing age

Effects of Modified Huangfeng Decoction on Long-Term Fertility and Immune Function of Patients with Systemic Lupus Eerythematosus and Antiphospholipid Antibody Syndrome at Childbearing Age

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048135

Enrollment

Unknown

Registered

2021-07-04

Start date

2021-07-31

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SLE

Interventions

Experimental group:Flavored Yellow Wind Soup

Control group:Conservative treatment

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women of childbearing age; 2. Systemic lupus erythematosus with antiphospholipid antibody syndrome; 3. Previous use of hormone and immunosuppressant therapy.

Exclusion criteria

Exclusion criteria: 1. You have received kidney replacement therapy; 2. A history of pregnancy.

Design outcomes

Primary

Measure	Time frame
Provincial top;urea nitrogen;complement C3;	—

Countries

China

Contacts

Public ContactMa Hongzhen

Zhejiang Provincial Hospital of Traditional Chinese Medicine

fanmlov@sina.cn+86 15258808620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026